Chinese Antibody Society

Home
Chinese Antibody Society

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Chinese Antibody Society, Pharmaceuticals, .

21/06/2019

Webinar this weekend: Toripalimab was China's first domestic anti-PD-1 antibody approved in 2018 for the 2nd line treatment of metastatic melanoma. Dr. Sheng Yao, the Board Executive Director and Senior Vice President of Shanghai Junshi Biosciences, will highlight the results of several toripalimab phase II studies released at this year’s ASCO annual meeting,focusing on prognostic or resistance biomarkers and biomarker-guided treatment strategies when comparing clinical studies in Asia vs Europe/US. Register at :https://chineseantibody.org/webinar/

13/06/2019

Upcoming webinar: Toripalimab was China's first domestic anti-PD-1 antibody approved in 2018 for the 2nd line treatment of metastatic melanoma. Dr. Sheng Yao, the Board Executive Director and Senior Vice President of Shanghai Junshi Biosciences, will highlight the results of several toripalimab phase II studies released at this year’s ASCO annual meeting,focusing on prognostic or resistance biomarkers and biomarker-guided treatment strategies when comparing clinical studies in Asia vs Europe/US. Register at:https://chineseantibody.org/webinar/

10/06/2019

June 25 to 27, our partner organization AET will host Digital Week, a global 4-day series of free live educational webcasts and downloadable resources providing the latest insights for accelerating next generation antibodies to commercial success.
Register for free: https://lifesciences.knect365.com/antibody-engineering-us-dw/

07/06/2019

As Chimeric Antigen Receptor (CAR) molecules become increasingly popular, there are growing interests to test existing antibody collections in this format to broaden spectrum of its utility. Researchers from Dr. Sébastien Wälchli's group at Oslo University Hospital Norway herein presented an easy-to-follow method to isolate and express them. Read the full article at: https://academic.oup.com/abt/advance-article/doi/10.1093/abt/tbz007/5509366

18/05/2019

Experts' Perspectives is Chinese Antibody Society's new interview series with top experts in the field of therapeutic antibodies. In the first interview, Dr.Ira Pastan from NIH shared his insights on the challenges and opportunities for immunotoxin-based immunotherapy, and talked about his research which eventually led to an FDA approved drug moxetumomab pasudotox. Please stay tuned for future interviews.
https://chineseantibody.org/experts-perspectives/

13/05/2019

In this Editorial, Dr.Zhiqiang An and members of his group at the University of Texas Health Science Center at Houston talked about the history, current status and key future challenges for cancer immunotherapies. The 2018 Nobel Prize in Physiology or Medicine was awarded jointly to James Allison, Ph.D. and Tasuku Honjo, M.D., Ph.D., for their independent work pioneering strategies that enhance the immune response to tumor cells.
Read the full article at: https://academic.oup.com/abt/article/2/1/40/5380704

12/05/2019

Upcoming webinar: Dr.Haichun Huang, CSO of of NovaRock Biotherapeutics, will discuss several commonly used discovery platforms that made significant contributions to the successful development of therapeutic antibodies. She will also share personal experience in using hybridoma technology to discover and develop therapeutic antibodies and discuss a novel hybridoma cloning technology.
Register at: https://chineseantibody.org/webinar/

02/05/2019

Please join us at Antibody Engineering & Therapeutics, 11-13 June 2019 in Amsterdam, NL, the industry’s European meeting for antibody and protein therapeutic science, technology and networking. Chinese Antibody Society members receive an additional 10% discount with VIP Code.https://lifesciences.knect365.com/antibody-engineering-europe/?utm_source=ChineseAntibodySociety&utm_medium=Listing&utm_campaign=AET-EU19

29/04/2019

Thanks HMS-CSSA for organizing the successful 2019 Harvard Chinese Life Science Annual Symposium!

26/04/2019

Webinar Tomorrow: on April 27th 9pm EST, Dr.Susan Qu from Thermo Fisher Scientific will talk about quality in a GMP environment through the introduction and discussion of 1) quality key concepts; 2) the FDA Quality System Model and inspection trend; 3) integrated implementation of ICH Q8, Q9, Q10 for improved product quality and regulatory compliance. Register at: https://chineseantibody.org/webinar/ The webinars are free for registered Chinese Antibody Society members!

23/04/2019

Please join us at Antibody Engineering & Therapeutics, 11-13 June 2019 in Amsterdam, NL, the industry’s European meeting for antibody and protein therapeutic science, technology and networking. Chinese Antibody Society members receive an additional 10% discount with VIP Code.

https://lifesciences.knect365.com/antibody-engineering-europe/?utm_source=ChineseAntibodySociety&utm_medium=Listing&utm_campaign=AET-EU19

22/04/2019

With the recent approval of Sintilimab for the treatment of Classic Hodgkin's Lymphoma in China, totally four anti-PD-1 antibodies have been approved by the National Medical Products Administration of China (NMPA) for cancer immunotherapy.In this interview, Dr. Michael Yu, the chairman, CEO and president of Innovent Biologics, talked about the history of Sintilimab's development, and perspectives of anti-PD-1/PD-L1 antibodies in China. Read the original article for free: https://academic.oup.com/abt/article/2/2/54/5377834

Address

Website

https://chineseantibody.org/

Alerts

Be the first to know and let us send you an email when Chinese Antibody Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City: